Pregled bibliografske jedinice broj: 49455
Phenyl-imidazolium and quinuclidinium oximes as antidotes against organophosphorous and carbamate poisoning
Phenyl-imidazolium and quinuclidinium oximes as antidotes against organophosphorous and carbamate poisoning // Technical Program of CB Medical Treatment Symposium: The Second Chemical and Biological Medical Treatment Symposium / Price, Richard (ur.).
Spiez: ASA, 1996. str. 15-16 (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 49455 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Phenyl-imidazolium and quinuclidinium oximes as
antidotes against organophosphorous and
carbamate poisoning
Autori
Radić, Božica ; Lucić, Ana ; Primožič, Ines ; Binenfeld, Zlatko
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Technical Program of CB Medical Treatment Symposium: The Second Chemical and Biological Medical Treatment Symposium
/ Price, Richard - Spiez : ASA, 1996, 15-16
Skup
CB Medical Treatment Symposium, The Second Chemical and Biological Medical Treatment Symposium
Mjesto i datum
Spiez, Švicarska, 07.07.1996. - 12.07.1996
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
organophosphorus compounds ; carbamates ; AChE
Sažetak
The in vitro activity of human erythrocyte acetylcholinesterase (AChE) and protective activity against soman, dichlorvos, and propoxur poisoning in male mice (in vivo experiments) were determined by using bis- phenyl imidazolium (2B) and imidazole- quinuclidinium oximes (BM-1). Oxime 2B strongly inhibits the AChE, and has a good reactivation potency, but weak protective ability, against AChe inhibited by these agents. Oxime BM-1 inhibits weakly AChE and its in vitro activity against inhibited AChE is negligible. In vivo, this oxime is a very good protective agent agains inhibitors tested in this paper. BM-1, given with atropine sulphate, provided a 100% protection in male mice against 4 x LD 50 soman, 11 x LD 50 dichlorovos, and 16 x LD 50 propoxur, respectively. The results indicate that in vivo effectiveness of quinuclidinium oxime is not related to its reactivating or protective potentials for AChE, as shown by the in vitro experiments. The in vivo action of this BM-1 oxime must be attributed to mechanisms not yet well defined.
Izvorni jezik
Engleski
Znanstvena područja
Kemija, Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
00220105
Ustanove:
Institut za medicinska istraživanja i medicinu rada, Zagreb,
Prirodoslovno-matematički fakultet, Zagreb
Profili:
Zlatko Binenfeld
(autor)
Ana Lucić Vrdoljak
(autor)
Ines Primožič
(autor)
Božica Radić
(autor)